If you have a kidney problem, you might need to take a lower dosage of Januvia. In this case, your doctor may prescribe you 25 mg or 50 mg of the drug once per day. This is because the kidneys ...

Through Week 54 they were: upper respiratory tract infection sitagliptin, and types of this metformin januvia 50mg epidemic, patients with inadequate glycemic control on a stable dose of the ...

What’s the Januvia 100-mg tablet price in the U.S.A., compared to the 25-mg or 50-mg tablets? The cost of Januvia tablets in the U.S.A. will depend on many factors, including: your insurance ...

WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved expanded labeling for JANUVIA(TM) (sitagliptin), the only DPP-4 ...

50 mg, and 100 mg The medication is a generic of Merck Sharpe and Dohme’s Januvia. Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with ...

Selected important risk information about JANUVIA (sitagliptin) 25 mg, 50 mg and 100 mg tablets (continued) There have been postmarketing reports of acute pancreatitis, including fatal and ...

Five New Studies at Major Medical Meeting Further Demonstrate Clinical Experience for JANUVIA ™ (sitagliptin) Study Data Show Longer Term Efficacy and Safety and Tolerability Profile of JANUVIA ...

Indications and Limitations of Use for JANUVIA ® (sitagliptin) 25 mg, 50 mg and 100 mg tablets JANUVIA is indicated, as an adjunct to diet and exercise, to improve glycemic control in adults with ...

Since metformin is administered twice daily, in this study sitagliptin was given as 50 mg twice daily to allow for co-administration of the two treatments. The approved dose for JANUVIA is 100 mg ...

Merck says it will develop three other strengths based on 50 mg of Januvia. The company has also agreed to conduct post-marketing studies comparing blood-sugar control in patients on Januvia alone ...

The mean reduction in HbA1c -- a common measure of blood glucose -- in a study involving Januvia 50 mg and metformin 1,000 mg twice-daily was 1.8 percent after the first year and 1.7 percent at ...

The popular diabetes drug Januvia may contain traces of a probable carcinogen, but patients should keep using the medication because it could be dangerous to stop taking it, the U.S. Food and Drug ...